Hangzhou Kang Sheng Health Management Consulting Co., a Chinese firm offering diabetes management equipment, has completed a US$100 million series C financing round, totaling from a series C1 and C2 round, according to a today’s statement.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access Over 11,000 stories and data posts over the past 8 years!
Register NowAlready have an account or paid subscription? Log in
